Belgian technology company Materialise has announced an investment in Replasia, a Belgian medical technology start-up focused on hip preservation. The company develops anatomical analysis software alongside personalized, 3D printed devices intended to delay or avoid joint replacement. For Materialise, the move reflects a view that individualized treatment can influence clinical results and that preserving the…
Belgian technology company Materialise has announced an investment in Replasia, a Belgian medical technology start-up focused on hip preservation. The company develops anatomical analysis software alongside personalized, 3D printed devices intended to delay or avoid joint replacement. For Materialise, the move reflects a view that individualized treatment can influence clinical results and that preserving the…